These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 23301671

  • 1. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
    Carina V, Zito G, Pizzolanti G, Richiusa P, Criscimanna A, Rodolico V, Tomasello L, Pitrone M, Arancio W, Giordano C.
    Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY, Wong G, Earle C, Chen L.
    J Biol Chem; 2012 Sep 21; 287(39):32800-24. PubMed ID: 22847005
    [Abstract] [Full Text] [Related]

  • 3. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH, Liu AG, Gu WG, Deng L, Cheng XG, Tong TJ, Zhang HZ.
    Oncol Rep; 2013 Aug 21; 30(2):815-23. PubMed ID: 23708735
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells.
    Zheng X, Cui D, Xu S, Brabant G, Derwahl M.
    Int J Oncol; 2010 Aug 21; 37(2):307-15. PubMed ID: 20596658
    [Abstract] [Full Text] [Related]

  • 9. Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation.
    Divya MS, Roshin GE, Divya TS, Rasheed VA, Santhoshkumar TR, Elizabeth KE, James J, Pillai RM.
    Stem Cell Res Ther; 2012 Dec 19; 3(6):57. PubMed ID: 23253356
    [Abstract] [Full Text] [Related]

  • 10. MYC Regulates the HIF2α Stemness Pathway via Nanog and Sox2 to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells.
    Das B, Pal B, Bhuyan R, Li H, Sarma A, Gayan S, Talukdar J, Sandhya S, Bhuyan S, Gogoi G, Gouw AM, Baishya D, Gotlib JR, Kataki AC, Felsher DW.
    Cancer Res; 2019 Aug 15; 79(16):4015-4025. PubMed ID: 31266772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
    Yang J, Liao D, Chen C, Liu Y, Chuang TH, Xiang R, Markowitz D, Reisfeld RA, Luo Y.
    Stem Cells; 2013 Feb 15; 31(2):248-58. PubMed ID: 23169551
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Kocdor MA, Cengiz H, Ates H, Kocdor H.
    Anticancer Agents Med Chem; 2019 Feb 15; 19(15):1887-1898. PubMed ID: 31584382
    [Abstract] [Full Text] [Related]

  • 14. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
    Upadhyay VA, Shah KA, Makwana DP, Raval AP, Shah FD, Rawal RM.
    J Cancer Res Ther; 2020 Feb 15; 16(4):804-810. PubMed ID: 32930122
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
    Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B, Walzer SM, Windhager R, Leithner A.
    PLoS One; 2012 Feb 15; 7(8):e43664. PubMed ID: 22928012
    [Abstract] [Full Text] [Related]

  • 18. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y, Zhao H, Lan F, Lee A, Chen L, Lin C, Yao Y, Li L.
    Cell Reprogram; 2010 Jun 15; 12(3):237-47. PubMed ID: 20698766
    [Abstract] [Full Text] [Related]

  • 19. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
    Yun JY, Kim YA, Choe JY, Min H, Lee KS, Jung Y, Oh S, Kim JE.
    J Clin Pathol; 2014 Feb 15; 67(2):125-33. PubMed ID: 23986551
    [Abstract] [Full Text] [Related]

  • 20. Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.
    Lettnin AP, Wagner EF, Carrett-Dias M, Dos Santos Machado K, Werhli A, Cañedo AD, Trindade GS, de Souza Votto AP.
    Mol Biol Rep; 2019 Apr 15; 46(2):1873-1884. PubMed ID: 30721421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.